Bionano Genomics (BNGO) Inventory (2017 - 2026)

Bionano Genomics (BNGO) has 10 years of Inventory data on file, last reported at $5.3 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory fell 44.5% year-over-year to $5.3 million; the trailing twelve-month figure through Mar 2026 stood at $5.3 million (down 44.5% YoY), and the FY2025 full-year result was $5.4 million, down 51.01% from the prior year.
• Inventory retreated to $5.3 million in Q1 2026, from $5.4 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $33.1 million in Q1 2023 to a low of $5.3 million in Q1 2026.
• A 5-year average of $18.1 million and a median of $19.5 million in 2024 frame the typical range for Inventory.
• Across the five-year window, Inventory jumped 435.84% in 2022 and plunged 55.67% in 2025, its largest moves.
• Tracing BNGO's Inventory over 5 years: stood at $29.8 million in 2022, then retreated by 23.08% to $22.9 million in 2023, then sank by 51.42% to $11.1 million in 2024, then sank by 51.01% to $5.4 million in 2025, then retreated by 2.59% to $5.3 million in 2026.
• Business Quant data shows BNGO's Inventory at $5.3 million in Q1 2026, $5.4 million in Q4 2025, and $7.0 million in Q3 2025.